An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis

Trial Profile

An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs Naftifine (Primary)
  • Indications Tinea corporis
  • Focus Pharmacokinetics
  • Sponsors Merz Pharma
  • Most Recent Events

    • 12 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Oct 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
    • 11 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top